BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Uterine cancer AND ACVR2A, ACVR2, 92, ENSG00000121989, ACTRII, P27037 AND Staging
305 results:

  • 1. Accuracy of MRI in predicting deep myometrial invasion in endometrial cancer and the influence of leiomyoma, adenomyosis and the microcystic elongated and fragmented tumour pattern.
    Liyanage A; Cardoza S; Kasabia D; Moore H
    J Med Imaging Radiat Oncol; 2024 Apr; 68(3):235-242. PubMed ID: 38377045
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Consistency between Primary uterine Corpus Malignancies and Their Corresponding Patient-Derived Xenograft Models.
    Ueda S; Tanaka T; Hirosuna K; Miyamoto S; Murakami H; Nishie R; Tsuchihashi H; Toji A; Morita N; Hashida S; Daimon A; Terada S; Maruoka H; Kogata Y; Taniguchi K; Komura K; Ohmichi M
    Int J Mol Sci; 2024 Jan; 25(3):. PubMed ID: 38338763
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Radiomics Analysis of Multiparametric PET/MRI for N- and M-staging in Patients with Primary Cervical cancer.
    Umutlu L; Nensa F; Demircioglu A; Antoch G; Herrmann K; Forsting M; Grueneisen JS
    Nuklearmedizin; 2024 Feb; 63(1):34-42. PubMed ID: 38325362
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Validation of Sentinel Lymph Node Biopsy in Robotic Endometrial cancer staging Surgery: Results From a High-Volume Center in India.
    Roy A; Rout S; Bhaumik J
    JCO Glob Oncol; 2023 Sep; 9():e2200347. PubMed ID: 38085045
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Oncologic outcomes of robot-assisted laparoscopy versus conventional laparoscopy for the treatment of apparent early-stage endometrioid adenocarcinoma of the uterus.
    Lim YH; Dagher C; Abu-Rustum NR; Mueller JJ; Sonoda Y; Zivanovic O; Broach V; Leitao MM
    Gynecol Oncol; 2023 Dec; 179():152-157. PubMed ID: 37980770
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Mapping sentinel lymph nodes in early-stage ovarian cancer (MELISA) trial - a further step towards lymphadenectomy replacement.
    Agustí N; Vidal-Sicart S; Paredes P; Celada-Castro C; Migliorelli F; Glickman A; Marina T; Fusté P; Carreras-Dieguez N; Saco A; Díaz-Feijóo B; Torné A
    Gynecol Oncol; 2023 Dec; 179():145-151. PubMed ID: 37980769
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Oncologic and Fertility Outcomes After Simple Trachelectomy in Women With Early Cervical cancer.
    Siegler K; Plaikner A; Hertel H; Hasenbein K; Petzel A; Schubert M; Blohmer JU; Böhmer G; Marnitz S; Ragosch V; Domröse C; Oppelt P; Jülicher A; Schneider A; Willems A; Favero G; Köhler C
    J Minim Invasive Gynecol; 2024 Feb; 31(2):110-114. PubMed ID: 37951567
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Lymph node staging in grade 1-2 endometrioid ovarian carcinoma apparently confined to the ovary: Is it worth?
    Bizzarri N; Imterat M; Fruscio R; Giannarelli D; Perrone AM; Mancari R; Traut A; Rosati A; du Bois A; Ferrari D; De Iaco P; Ergasti R; Ataseven B; Bianchi T; Di Stanislao M; Perri MT; Heitz F; Concin N; Fanfani F; Vizza E; Scambia G; Harter P; Fagotti A
    Eur J Cancer; 2023 Dec; 195():113398. PubMed ID: 37890354
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Establishment of prediction models to predict survival among patients with cervical cancer based on socioeconomic factors: a retrospective cohort study based on the SEER Database.
    Jia X; Zhou J; Fu Y; Ma C
    BMJ Open; 2023 Oct; 13(10):e072556. PubMed ID: 37827746
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Survival after sentinel lymph node biopsy for early cervical cancers: a systematic review and meta-analysis.
    Parpinel G; Laas-Faron E; Balaya V; Guani B; Zola P; Mathevet P; Paoletti X; Lecuru FR
    Int J Gynecol Cancer; 2023 Dec; 33(12):1853-1860. PubMed ID: 37696646
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Recurrence Risk Stratification for Women With FIGO Stage I uterine Endometrioid Carcinoma Who Underwent Surgical Lymph Node Evaluation.
    Ghanem AI; Bhatnagar A; Elshaikh M; Hijaz M; Elshaikh MA
    Am J Clin Oncol; 2023 Dec; 46(12):537-542. PubMed ID: 37679878
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Delineation of clinical target volume and organs at risk in cervical cancer radiotherapy by deep learning networks.
    Tian M; Wang H; Liu X; Ye Y; Ouyang G; Shen Y; Li Z; Wang X; Wu S
    Med Phys; 2023 Oct; 50(10):6354-6365. PubMed ID: 37246619
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Study on the preoperative value of serum SCC-Ag in predicting the stromal invasion of cervical squamous cell carcinoma.
    Qin L
    J Cancer Res Clin Oncol; 2023 Sep; 149(11):9167-9171. PubMed ID: 37184678
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Success Rates of Sentinel Lymph Node Mapping for Endometrial cancer in Patients with Body Mass Index < 45 Compared with Body Mass Index ≥ 45.
    Fennimore NJ; Fitch K; Kiff J; Nguyen CG; Garg B; Munro EG; Bruegl AS
    J Minim Invasive Gynecol; 2023 Sep; 30(9):735-741. PubMed ID: 37142090
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Diagnostic accuracy of MRI for evaluating myometrial invasion in endometrial cancer: a comparison of MUSE-DWI, rFOV-DWI, and DCE-MRI.
    Ota T; Tsuboyama T; Onishi H; Nakamoto A; Fukui H; Yano K; Honda T; Kiso K; Tatsumi M; Tomiyama N
    Radiol Med; 2023 Jun; 128(6):629-643. PubMed ID: 37120661
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Effect of lymph node sampling type on oncologic outcomes in endometrial cancers: comprehensive pelvic and paraaortic lymphadenectomy vs. sentinel lymph node mapping with indocyanine green.
    Kulhan M; Bilgi A; Avcı F; Kulhan NG; Celik C; Ucar MG
    Eur Rev Med Pharmacol Sci; 2023 Apr; 27(7):3096-3104. PubMed ID: 37070913
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. The impact of lymphovascular space invasion on survival in early stage low-grade endometrioid endometrial cancer.
    Yarandi F; Shirali E; Akhavan S; Nili F; Ramhormozian S
    Eur J Med Res; 2023 Mar; 28(1):118. PubMed ID: 36915143
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Is Substantial Lymphovascular Space Invasion Prognostic in Patients With Pathologically Lymph Node-Negative Endometrial cancer?
    Pifer PM; Jaishankar S; Bhargava R; Schad MD; Keller A; Musunuru HB; Cohen M; Sukumvanich P; Courtney-Brooks M; Boisen M; Berger JL; Olawaiye A; Lesnock J; Edwards R; Taylor S; Vargo JA; Beriwal S
    Int J Radiat Oncol Biol Phys; 2023 Sep; 117(1):148-153. PubMed ID: 36893818
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Multicentric development and evaluation of
    Lucia F; Bourbonne V; Pleyers C; Dupré PF; Miranda O; Visvikis D; Pradier O; Abgral R; Mervoyer A; Classe JM; Rousseau C; Vos W; Hermesse J; Gennigens C; De Cuypere M; Kridelka F; Schick U; Hatt M; Hustinx R; Lovinfosse P
    Eur J Nucl Med Mol Imaging; 2023 Jul; 50(8):2514-2528. PubMed ID: 36892667
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. The prognostic value of the presence of pelvic and/or para-aortic lymph node metastases in cervical cancer patients; the influence of the new FIGO classification (stage IIIC).
    van Kol KGG; Ebisch RMF; van der Aa M; Wenzel HB; Piek JMJ; Bekkers RLM
    Gynecol Oncol; 2023 Apr; 171():9-14. PubMed ID: 36804623
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 16.